• The Pending NDC and Barcode Rule: Manufacturers’ Perspectives

    January 23, 2023

    The FDA has proposed an amendment to its regulations to adopt a uniform, 12-digit format for the NDC. HDA’s Senior Director, Industry Relations, Tim Stearns discusses the NDC and barcode proposed amendments and analyzes manufacturers' comments.

  • Transitioning COVID-19 Product Distribution to the Commercial Market

    January 11, 2023

    Throughout the COVID-19 pandemic, the federal government has primarily coordinated response efforts with the support of the private sector to develop, produce and distribute vaccines, personal protective equipment (PPE) and therapeutics. While this public health crisis continues, government and private-sector stakeholders are already thinking about the expected transition of COVID-19 product distribution to the commercial market — which could happen as early as the first quarter of this year.

  • Chip Davis Discusses HDA’s 2023 Priorities in Annual Chain Drug Review Column

    January 09, 2023

    With the welcoming of the new year and 118th Congress, HDA’s President and CEO Chip Davis penned an overview of the association’s 2023 priorities for the January 9 issue of Chain Drug Review.

  • Reimagining the Pharmaceutical Supply Chain

    December 22, 2022

    HDA's President and CEO Chip Davis participated in a panel discussion at The Milken Institute’s 2022 Future of Health Summit entitled, “Reimagining the Pharmaceutical Supply Chain in the United States,” discussing the fundamental resilience of the pharmaceutical supply chain, while exploring the gaps and deepened growing health inequities unearthed by recent public health events.

  • Less Than a Year From the DSCSA Deadline, Experts Discuss the Road to Compliance

    December 14, 2022

    The Drug Supply Chain Security Act (DSCSA) has entered its final year of implementation. For the past nine years, HDA has brought together supply chain partners, represented distributors’ insights and expertise with FDA and other regulators, and led educational initiatives aimed at informing and preparing supply chain stakeholders for 2023. At the October Traceability Seminar in Washington, D.C., HDA spoke with several industry experts, who were asked to share insights from across the DSCSA’s legislative and implementation process as part of our Faces of the Supply Chain series. Key highlights from these conversations are captured in this piece.

  • Member Spotlight: Henry Schein Celebrates 90 Years Delivering Healthcare Solutions

    December 05, 2022

    In honor of their 90th anniversary, Henry Schein is celebrating their organization’s transformation throughout the decades and embracing the opportunities ahead. To learn more about how the company has grown, and what the future holds, HDA recently spoke to Brad Connett, Chief Executive Officer, North America Distribution Group.

Have a Contribution? Get In Touch

John Parker
Senior Vice President, Communications

Farah Simonett
Vice President, Editorial and Internal Communications